Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › azithromycin

azithromycin

13 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of azithromycin

66 trials tracked of azithromycin: 37 in phase 3 or 4 and 23 with published results. The most-cited published study has 265 citations.

66Trials tracked
37Phase 3 & 4
0Recruiting
23With published results
Phase distribution
Phase 4 23 Phase 3 14 Phase 2 15 Phase 1 4 Other / NA 10
  1. Phase 3 Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids. Completed · 265 cited
  2. Phase 4 Lipids of the Human Tear Film and Their Effect on Tear Stability Completed · 168 cited
  3. Phase 3 OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis Completed · 98 cited
  4. Phase 4 Study of Azithromycin to Prevent Recurrent Trichiasis Following Surgery in Ethiopia Completed · 90 cited
  5. Phase 4 Trial of Azithromycin vs. Doxycycline for the Treatment of Rectal Chlamydia in MSM Completed · 78 cited
  6. Phase 4 Azithromycin - Ivermectin Mass Drug Administration for Skin Disease Completed · 71 cited
Show 44 more trials
  1. Phase 3 AZMATICS: AZithroMycin/Asthma Trial In Community Settings Completed · 69 cited
  2. Phase 4 Antibiotic Resistance and Microbiome in Children Aged 6-59 Months in Nouna, Burkina Faso Completed · 61 cited
  3. Phase 3 A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea Completed · 60 cited
  4. Phase 4 Mortality Reduction After Oral Azithromycin: Mortality Study Completed · 45 cited
  5. Phase 4 Azithromycin for Child Survival in Niger: Mortality and Resistance Trial Completed · 42 cited
  6. Phase 4 Neonates and Azithromycin, an Innovation in the Treatment of Children in Burkina Faso Completed · 40 cited
  7. Phase 4 Partnership for Rapid Elimination of Trachoma Completed · 33 cited
  8. Phase 3 Comparison of Two Different Doses of Azithromycin for Treatment of Yaws Completed · 28 cited
  9. Phase 3 Zoliflodacin in Uncomplicated Gonorrhoea Completed · 25 cited
  10. Phase 4 MORDOR II Burkina Faso: Longitudinal Trial Completed · 13 cited
  11. Phase 3 Azithromycin-Prevention in Labor Use Study (A-PLUS) Completed · 11 cited
  12. Phase 3 Azithromycin for Uncomplicated Severe Acute Malnutrition in Burkina Faso (Pilot) Completed · 9 cited
  13. Phase 4 Gut and Azithromycin Mechanisms in Infants and Children II Completed · 5 cited
  14. Phase 4 Azithromycin Reduction to Reach Elimination of Trachoma Completed · 5 cited
  15. Phase 3 Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex Completed · 2 cited
  16. Phase 4 Community Health Azithromycin Trial in Burkina Faso Completed · 1 cited
  17. Phase 4 Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries Completed
  18. Phase 4 Duration of Antibiotic Therapy as Part of Maximal Medical Therapy for Chronic Rhinosinusitis Completed
  19. Phase 4 Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF) Completed
  20. Phase 4 Mortality Reduction After Oral Azithromycin Contingency: Mortality Study Completed
  21. Phase 4 Trial Comparing Ceftriaxone Plus Azithromycin Versus Ceftriaxone for the Treatment of Gonorrhea Completed
  22. Phase 4 Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers Completed
  23. Phase 4 Efficacy of Combination Therapies for Gonorrhea Treatment Completed
  24. Phase 4 Efficacy of Azithromycin in Treatment of Bronchiectasis Completed
  25. Phase 4 Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger Completed
  26. Phase 4 Azithromycin in Bronchiolitis Obliterans Syndrome Completed
  27. Phase 3 The Study Of Azithromycin Switch Therapy For Treatment Of Community Acquired Pneumonia (CAP) Completed
  28. Phase 3 Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA) Completed
  29. Phase 3 Chloroquine Alone or in Combination for Malaria in Children in Malawi Completed
  30. Phase 3 Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan Completed
  31. Phase 3 Treatment Failure of Chlamydial Infection in Males and Females in Youth Correctional Facilities Completed
  32. Phase 2 Oral Azithromycin Versus Doxycycline in Posterior Blepharitis Completed
  33. Phase 2 Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease Completed
  34. Phase 2 Targeted Therapy of Bronchiolitis Obliterans Syndrome Completed
  35. Phase 2 Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19 Completed
  36. Phase 2 Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants Completed
  37. Phase 2 YCFM (Youth Correctional Facilities Males) Completed
  38. Phase 2 Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis Completed
  39. Phase 2 Antibiotic Treatment Trial for the PANDAS/PANS Phenotype Completed
  40. Phase 2 Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis Completed
  41. Phase 2 Pertussis Challenge Study in Adults Vaccinated With BPZE1 Completed
  42. Phase 2 Personalized Treatment Algorithms for Difficult-to-treat Asthma Completed
  43. Phase 2 Preschool Wheeze: Inflammation/Infection Guided Management Completed
  44. Phase 2 NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole) Completed

Showing the 50 most-cited and recently-updated of 66 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Intrapartum azithromycin reduces maternal infection risk regardless of time to delivery
Infectious Disease RCT
Intrapartum azithromycin reduces maternal infection risk regardless of time to delivery Study finds timing of antibiotic in labor may not affect maternal infection prevention
A secondary analysis of an RCT in 29,236 pregnant patients found intrapartum azithromycin reduced maternal infection risk (RR 0.71) regardle…
Giving azithromycin during labor cuts maternal infection risk by 29% regardless of timing, but offers no protection for newborns.
Apr 4, 2026